Syscoin Achieves Market Capitalization of $69.90 Million (SYS)

Syscoin (CURRENCY:SYS) traded 7.6% lower against the U.S. dollar during the 24 hour period ending at 7:00 AM Eastern on August 2nd. One Syscoin coin can now be bought for approximately $0.13 or 0.00001715 BTC on cryptocurrency exchanges including Trade By Trade, Sistemkoin, Bittylicious and Tux Exchange. Syscoin has a market capitalization of $69.90 million and $751,859.00 worth of Syscoin was traded on exchanges in the last 24 hours. In the last week, Syscoin has traded 22.8% lower against the U.S. dollar.

Here is how other cryptocurrencies have performed in the last 24 hours:

Get Syscoin alerts: Litecoin (LTC) traded down 1.3% against the dollar and now trades at $77.03 or 0.01016183 BTC. Dogecoin (DOGE) traded 1.2% higher against the dollar and now trades at $0.0030 or 0.00000040 BTC. Verge (XVG) traded down 6.1% against the dollar and now trades at $0.0212 or 0.00000279 BTC. Bytom (BTM) traded 1.3% lower against the dollar and now trades at $0.30 or 0.00003944 BTC. Polymath (POLY) traded down 11.3% against the dollar and now trades at $0.32 or 0.00004225 BTC. CyberMiles (CMT) traded down 2.5% against the dollar and now trades at $0.12 or 0.00001579 BTC. Matrix AI Network (MAN) traded 0.7% lower against the dollar and now trades at $0.38 or 0.00004951 BTC. Viacoin (VIA) traded down 2% against the dollar and now trades at $1.18 or 0.00015606 BTC. Einsteinium (EMC2) traded down 3% against the dollar and now trades at $0.11 or 0.00001507 BTC. BridgeCoin (BCO) traded down 7.7% against the dollar and now trades at $0.91 or 0.00012055 BTC.

Syscoin Profile

Syscoin is a proof-of-work (PoW) coin that uses the Scrypt hashing algorithm. Its launch date was April 27th, 2014. Syscoin’s total supply is 537,699,848 coins. The official website for Syscoin is syscoin.org. The Reddit community for Syscoin is /r/SysCoin and the currency’s Github account can be viewed here. Syscoin’s official Twitter account is @syscoin and its Facebook page is accessible here.

Buying and Selling Syscoin

Syscoin can be bought or sold on the following cryptocurrency exchanges: Trade By Trade, Poloniex, Binance, Bittrex, Upbit, Bittylicious, YoBit, Livecoin, Sistemkoin and Tux Exchange. It is usually not possible to purchase alternative cryptocurrencies such as Syscoin directly using US dollars. Investors seeking to acquire Syscoin should first purchase Ethereum or Bitcoin using an exchange that deals in US dollars such as Gemini, Changelly or GDAX. Investors can then use their newly-acquired Ethereum or Bitcoin to purchase Syscoin using one of the aforementioned exchanges.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “SYSUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

James Investment Research Inc. Boosts Stake in American Equity Investment Life Holding (AEL)

James Investment Research Inc. lifted its holdings in American Equity Investment Life Holding (NYSE:AEL) by 3.6% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 129,688 shares of the financial services provider’s stock after purchasing an additional 4,521 shares during the period. James Investment Research Inc.’s holdings in American Equity Investment Life were worth $4,669,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Vigilant Capital Management LLC purchased a new position in shares of American Equity Investment Life in the second quarter worth about $112,000. Point72 Asia Hong Kong Ltd purchased a new position in shares of American Equity Investment Life in the first quarter worth about $188,000. BKS Advisors LLC purchased a new position in shares of American Equity Investment Life in the first quarter worth about $207,000. GSA Capital Partners LLP purchased a new position in shares of American Equity Investment Life in the first quarter worth about $233,000. Finally, Xact Kapitalforvaltning AB purchased a new position in shares of American Equity Investment Life in the fourth quarter worth about $254,000. 93.45% of the stock is currently owned by hedge funds and other institutional investors.

Get American Equity Investment Life alerts:

Shares of American Equity Investment Life opened at $35.14 on Friday, Marketbeat Ratings reports. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.29. American Equity Investment Life Holding has a 12 month low of $25.43 and a 12 month high of $37.16. The stock has a market cap of $3.17 billion, a price-to-earnings ratio of 10.52 and a beta of 2.49.

American Equity Investment Life (NYSE:AEL) last issued its earnings results on Wednesday, May 2nd. The financial services provider reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.01. American Equity Investment Life had a net margin of 8.49% and a return on equity of 11.22%. The company had revenue of $510.78 million for the quarter, compared to the consensus estimate of $514.11 million. During the same period in the previous year, the firm earned $0.66 earnings per share. research analysts anticipate that American Equity Investment Life Holding will post 3.43 EPS for the current fiscal year.

Several equities analysts have recently weighed in on AEL shares. ValuEngine raised shares of American Equity Investment Life from a “hold” rating to a “buy” rating in a research note on Tuesday, May 22nd. Zacks Investment Research raised shares of American Equity Investment Life from a “hold” rating to a “buy” rating and set a $31.00 price target on the stock in a research note on Friday, May 4th. Sandler O’Neill reissued a “buy” rating and issued a $41.00 price target on shares of American Equity Investment Life in a research note on Friday, July 13th. Finally, UBS Group raised shares of American Equity Investment Life from a “sell” rating to a “neutral” rating in a research note on Friday, May 4th. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $33.88.

American Equity Investment Life Profile

American Equity Investment Life Holding Company, through its subsidiaries, provides life insurance products and services in the United States. The company issues fixed index and rate annuities; and single premium immediate annuities, as well as life insurance products. The company markets its products through various distribution channels, including national marketing organizations, broker/dealers, banks, and registered investment advisors.

See Also: Short Selling

Want to see what other hedge funds are holding AEL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Equity Investment Life Holding (NYSE:AEL).

Top 10 Warren Buffett Stocks To Own For 2019

tags:CORT,TRMK,ELGX,FLO,CLS,FB,WMT,GLBS,OKE,LBIX,

It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.
Whether we're talking about socks or stocks, I like buying quality merchandise when it is marked down.
- Warren Buffett

What is a wonderful company, and what is 'quality' from an investing standpoint? The most constructive definition to address these questions is Warren Buffett's concept of 'economic moat', i.e. a long-lasting competitive advantage that allows a given company to harvest above-average returns on its capital, even when faced with economic downturns or powerful competitors. A quality investing strategy should therefore capture the fundamental nature of Buffet's philosophy. Our aim is to identify quality stocks at reasonable prices by calculating a simple Quality Score based on 12 fundamental factors.

These factors are the ones that best define the 'quality' dimension of a specific company, according to Buffett and to other investors in 'high quality' companies (like Charlie Munger, Chuck Akre, Joel Greenblatt or Tom Gayner). To calculate the Quality Score, we try to answer questions addressing the following aspects:

Top 10 Warren Buffett Stocks To Own For 2019: Corcept Therapeutics Incorporated(CORT)

Advisors' Opinion:

• [By Max Byerly]

  AJ Wealth Strategies LLC raised its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 113.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 441,103 shares of the biotechnology company’s stock after acquiring an additional 234,483 shares during the quarter. Corcept Therapeutics comprises approximately 1.4% of AJ Wealth Strategies LLC’s portfolio, making the stock its 14th biggest holding. AJ Wealth Strategies LLC owned approximately 0.38% of Corcept Therapeutics worth $6,934,000 as of its most recent SEC filing.

• [By Ethan Ryder]

  ValuEngine lowered shares of Corcept Therapeutics (NASDAQ:CORT) from a buy rating to a hold rating in a research note issued to investors on Friday.

• [By Logan Wallace]

  Sei Investments Co. lessened its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 27.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,279 shares of the biotechnology company’s stock after selling 5,271 shares during the quarter. Sei Investments Co.’s holdings in Corcept Therapeutics were worth $235,000 at the end of the most recent reporting period.

• [By Lisa Levin] Gainers McDermott International, Inc. (NYSE: MDR) rose 19 percent to $7.20 in pre-market trading. Subsea 7 S.A. confirmed a $7.00 per share proposal to acquire McDermott. Clarus Corporation (NASDAQ: CLAR) rose 18.5 percent to $8.00 in pre-market trading. Enbridge Inc. (NYSE: ENB) rose 9.3 percent to $34.09 in pre-market trading after falling 2.41 percent on Friday. Lannett Company, Inc. (NYSE: LCI) rose 8.4 percent to $18 in pre-market trading. Lannett named Maureen M. Cavanaugh as senior vice president and chief commercial operations officer. Navios Maritime Midstream Partners L.P. (NYSE: NAP) rose 7.1 percent to $4.55 in pre-market trading after gaining 11.26 percent on Friday. Corcept Therapeutics Incorporated (NASDAQ: CORT) rose 6.9 percent to $18.80 in pre-market trading after falling 3.19 percent on Friday. Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 5.7 percent to $2.40 in pre-market trading after falling 10.98 percent on Friday. Vectren Corporation (NYSE: VVC) shares rose 5.6 percent to $69.20 in pre-market trading. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash Genprex, Inc. (NASDAQ: GNPX) shares rose 5.2 percent to $4.50 in pre-market trading. Atossa Genetics Inc. (NASDAQ: ATOS) rose 5.1 percent to $3.70 in pre-market trading after declining 19.35 percent on Friday. Sangamo Therapeutics, Inc. (NASDAQ: SGMO) shares rose 5 percent to $20 in pre-market trading. Magellan Midstream Partners, L.P. (NYSE: MMP) shares rose 5 percent to $68.41 in pre-market trading. Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares rose 4.9 percent to $19.78 in the pre-market trading session.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Warren Buffett Stocks To Own For 2019: Trustmark Corporation(TRMK)

Advisors' Opinion:

• [By Stephan Byrd]

  Rhumbline Advisers lowered its position in Trustmark Corp (NASDAQ:TRMK) by 5.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 122,924 shares of the financial services provider’s stock after selling 7,773 shares during the quarter. Rhumbline Advisers owned about 0.18% of Trustmark worth $3,830,000 at the end of the most recent quarter.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Trustmark (TRMK)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Trustmark (NASDAQ: TRMK) and Valley National Bank (NYSE:VLY) are both mid-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.

Top 10 Warren Buffett Stocks To Own For 2019: Endologix, Inc.(ELGX)

Advisors' Opinion:

• [By Ethan Ryder]

  Here are some of the news headlines that may have impacted Accern’s analysis:

  Get Endologix alerts: Endologix Reports Positive One-Year Results From the Ovation LUCY Study (dicardiology.com) Endologix, Inc. to Announce Second Quarter 2018 Financial Results on August 9, 2018 (finance.yahoo.com) Stock Under Active Eyes: Endologix, Inc. (ELGX) (bitcoinpriceupdate.review) Endologix, Inc. (ELGX) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com) Endologix Inc. to Post FY2016 Revenue of ($0.71) Per Share, Leerink Swann Forecasts (ELGX) (bharatapress.com)

  NASDAQ:ELGX traded down $0.09 on Tuesday, hitting $5.42. 4,339 shares of the stock were exchanged, compared to its average volume of 483,122. The firm has a market capitalization of $462.06 million, a PE ratio of -11.31 and a beta of 0.44. The company has a debt-to-equity ratio of 3.58, a current ratio of 2.13 and a quick ratio of 1.37. Endologix has a fifty-two week low of $3.75 and a fifty-two week high of $6.72.

• [By Stephan Byrd]

  Endologix (NASDAQ:ELGX) was upgraded by investment analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Wednesday.

Top 10 Warren Buffett Stocks To Own For 2019: Flowers Foods, Inc.(FLO)

Advisors' Opinion:

• [By Max Byerly]

  Novare Capital Management LLC lowered its holdings in Flowers Foods, Inc. (NYSE:FLO) by 35.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,835 shares of the company’s stock after selling 7,115 shares during the quarter. Novare Capital Management LLC’s holdings in Flowers Foods were worth $281,000 at the end of the most recent reporting period.

• [By Shane Hupp]

  Schwab Charles Investment Management Inc. boosted its stake in shares of Flowers Foods, Inc. (NYSE:FLO) by 14.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,940,432 shares of the company’s stock after purchasing an additional 246,581 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Flowers Foods were worth $42,418,000 at the end of the most recent quarter.

• [By Stephan Byrd]

  Flowers Foods (NYSE:FLO) was upgraded by analysts at Consumer Edge from a neutral rating to an outperform rating.

  Hawaiian Electric Industries (NYSE:HE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Hawaiian Electric kick started 2018 on a mixed note. While the company’s first-quarter earnings came in line with the Zacks Consensus Estimate, revenues beat the consensus mark. The company is the largest provider of electricity in the state of Hawaii, as a result of which it outperformed the broader industry in past twelve months. It continues to make systematic investments in utility infrastructure development projects, primarily adding new generation facilities, replacing aging infrastructure and restoring transmission and distribution assets. However, Hawaiian Electric depends heavily on third-party suppliers for fuel and purchased power. With the Federal Reserve set to hike interest rate thrice in 2018, Hawaiian Electric’s operational performance may get hampered in coming days. Fluctuations in the oil price in the global market tend to push up Hawaiian Electric’s expenses.”

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Flowers Foods (FLO)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  FlorinCoin (FLO) is a proof-of-work (PoW) coin that uses the Scrypt hashing algorithm. Its genesis date was June 17th, 2013. FlorinCoin’s total supply is 144,115,914 coins. FlorinCoin’s official website is flo.cash. FlorinCoin’s official Twitter account is @FLOblockchain and its Facebook page is accessible here. The Reddit community for FlorinCoin is /r/floblockchain and the currency’s Github account can be viewed here.

Top 10 Warren Buffett Stocks To Own For 2019: Celestica, Inc.(CLS)

Advisors' Opinion:

• [By Peter Graham]

  Nevertheless, a long term performance chart shows Sanmina Corp previously being an outperformer, but now falling off while�potential large cap peer Flextronics International Ltd (NASDAQ: FLEX) has given a steady performance over the last two years and small cap�Celestica Inc (NYSE: CLS) and mid cap�Jabil Circuit, Inc (NYSE: JBL) have similar unaspiring charts:

• [By Joseph Griffin]

  Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lessened its holdings in Celestica Inc (NYSE:CLS) (TSE:CLS) by 18.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,492,435 shares of the technology company’s stock after selling 343,300 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 1.20% of Celestica worth $19,894,000 as of its most recent filing with the Securities and Exchange Commission.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Celestica (CLS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Own For 2019: Facebook, Inc.(FB)

Advisors' Opinion:

• [By ]

  I am not a fan of Facebook (FB) or its CEO, and have never more than rented that name on either side around news events.

  That leaves Alphabet (GOOGL) . I am flat this name, but have been long more often than not over the past few years. I got rid of this one when I lost faith back in March. If I was going to buy it back, however, it sure looks like I probably have missed anything close to the bottom.

• [By Leo Sun]

  Unlike Facebook (NASDAQ:FB), which mainly connects users to their friends and family members, Twitter is designed as a soapbox for self-promotion. Since Twitter users with just a few followers weren't taken seriously, a black market for�selling fake followers flourished. Last year, The New York Times bought 25,000 followers for a test account for $225 to demonstrate how easily Twitter's follower counts cloud be inflated.

• [By Harsh Chauhan]

  Just 26% of 1.3 billion Indians had access to the internet in 2015, but the government believes that 338 million number will shoot up to 730 million by 2020, thanks to increasing penetration in the rural areas. The government in 2011 launched an effort to provide broadband connectivity to 250,000 local village governments, but that plan has hit a speed bump and Facebook's (NASDAQ:FB) internet.org is hoping to fill the gap.

• [By ]

  Facebook (FB) CEO Mark Zuckerberg testified before a host of Senators on Capitol Hill Tuesday to address the social media giant's recent data woes. 

Top 10 Warren Buffett Stocks To Own For 2019: Wal-Mart Stores, Inc.(WMT)

Advisors' Opinion:

• [By ] While Walmart (NYSE: WMT) has been in the news for all of the investment it has made in growing its digital business, the chain's warehouse club, Sam's Club, has only received media attention when the company decided to close 63 of the membership-based chain's locations.

• [By Paul Ausick]

  Retail giant Walmart Inc. (NYSE: WMT) announced Wednesday morning that it had pulled the trigger on a deal to acquire a controlling stake in India’s Flipkart Group, the country’s leading e-commerce platform. Walmart acquired a 77% stake in Flipkart for approximately $16 billion, which the company plans to fund through a combination of new debt and cash on hand.

• [By Daniel B. Kline]

  But while the company's stock has grown during that six month period, it currently sits below its highs (as of April 9). That's largely because Costco isn't particularly innovative. The company has a model that works, and while it tweaks it to account for changing consumer demands, it has not made the major shifts retailers like Target (NYSE:TGT) and Walmart (NYSE:WMT) have made to compete with Amazon.

Top 10 Warren Buffett Stocks To Own For 2019: Globus Maritime Limited(GLBS)

Advisors' Opinion:

• [By Joseph Griffin]

  Media coverage about Globus Maritime (NASDAQ:GLBS) has trended somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Globus Maritime earned a news impact score of 0.09 on Accern’s scale. Accern also assigned news articles about the shipping company an impact score of 45.6853785900783 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Warren Buffett Stocks To Own For 2019: ONEOK Inc.(OKE)

Advisors' Opinion:

• [By Reuben Gregg Brewer]

  Kinder Morgan, Inc. (NYSE:KMI) is one of the largest midstream companies in North America, and it has major dividend plans between 2018 and 2020. By the end of that period, it expects to increase its dividend from $0.50 per share per year (in 2017) to $1.25. That's huge dividend growth in a short period of time. But don't get too enamored by that news; the dividend will still be lower than it was before the midstream oil and gas company's 75% dividend cut in 2016. If you're looking for dividend income in the midstream space, take a look at longtime dividend payers ONEOK, Inc. (NYSE:OKE) and Magellan Midstream Partners, L.P. (NYSE:MMP) instead.� �

• [By Matthew DiLallo]

  ONEOK (NYSE:OKE) is off to a fast start in 2018. The pipeline and processing giant has benefited from the improvement in the oil market because drillers are completing more wells, which are flowing into its system. However, as good as the first quarter was, it's only the beginning for investors, which management made clear on the accompanying conference call with the following points:

• [By Lee Jackson]

  The volatile price of natural gas over the past year has weighed some on this top energy stock. ONEOK Inc. (NYSE: OKE) primarily engages in natural gas transportation, storage and natural gas and NGLs gathering, processing and fractionation in the Bakken, Mid-Continent and Permian. The company recently closed the roll-up of its underlying master limited partnership, ONEOK Partners.

• [By Shane Hupp]

  Here are some of the news articles that may have impacted Accern Sentiment’s rankings:

  Get ONEOK alerts: Analysts Anticipate ONEOK, Inc. (OKE) Will Announce Earnings of $0.66 Per Share (americanbankingnews.com) ONEOK (OKE) PT Set at $72.00 by Barclays (americanbankingnews.com) MARKETS: Why Bloomberg sees King Dollar reclaiming the throne (finance.yahoo.com) Keeping Tabs on the Levels for ONEOK, Inc. (NYSE:OKE): Change of -0.04 Since the Bell (stocknewscaller.com) Alluring Stocks: Lloyds Banking Group plc, (NYSE: LYG), ONEOK, Inc., (NYSE: OKE) (globalexportlines.com)

  NYSE OKE traded up $0.22 on Tuesday, hitting $69.24. 1,729,000 shares of the stock were exchanged, compared to its average volume of 2,754,345. ONEOK has a 52-week low of $47.14 and a 52-week high of $69.84. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.49 and a current ratio of 0.63. The stock has a market cap of $28.14 billion, a price-to-earnings ratio of 39.34, a PEG ratio of 2.75 and a beta of 1.27.

Top 10 Warren Buffett Stocks To Own For 2019: Leading Brands Inc(LBIX)

Advisors' Opinion:

• [By Joseph Griffin]

  Media headlines about Leading Brands (NASDAQ:LBIX) have trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Leading Brands earned a coverage optimism score of 0.21 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.3549545541136 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Hot Performing Stocks To Buy Right Now

tags:BIG,URBN,HSBC,

The dollar was under fresh pressure on Tuesday, notably from the British pound, which climbed on a forecast for interest-rate increases by a member of the Bank of England��s monetary policy committee.

With the move, the dollar retraced some of the gains that took it to its best levels since last year in recent trading sessions.

Check out: Being long the dollar is cool again

How are currencies performing?

The ICE U.S. Dollar Index DXY, -0.34% which measures the dollar against six rivals, was weaker at 93.368, from 93.630 late Monday. The index gained 1.2% last week, its strongest weekly gain since the period ending April 27, according to FactSet.

Hot Performing Stocks To Buy Right Now: Big Lots, Inc.(BIG)

Advisors' Opinion:

• [By Garrett Baldwin]
  Markets are cheering the jobs report, which easily topped expectations, this morning. In addition to a falling unemployment rate, the U.S. Department of Labor announced that U.S. hourly earnings increased by 0.3%. This report could provide the U.S. Federal Reserve with additional reasons to raise interest rates as concerns about inflation persist. The Fed has said it will raise interest rates two more times in 2018. However, the market has priced in a 30% chance that the Fed hikes rates three additional times. U.S. President Donald Trump has fired the opening rounds of a possible trade war. The United States hit the European Union, Canada, and Mexico with tariffs on steel and aluminum. Canada responded yesterday with retaliatory measures to target similar U.S. products. Crude oil prices fell Friday as markets continue to eye OPEC's next move. According to reports, Saudi Arabia and Russia have discussed plans to increase total production by 1 million barrels per day. The uptick would aim to address falling production in Venezuela and U.S. sanctions in Iran. The rumors come as U.S. production is sitting at near-record highs and is rivaling the output of Russia. These factors are part of a wider list of issues that will only continue to press oil prices lower in the months ahead. Three Stocks to Watch Today: DB, AAPL, TWTR Deutsche Bank AG�(NYSE: DB) is facing a possible crisis. S&P Global Ratings cut the company's credit rating and said that there are "significant execution risks" in its turnaround strategy. The credit downgrade came one day after the Fed said the German bank's American arm is "troubled." DB stock is off 0.5% this morning. Shares of Apple Inc. (Nasdaq: AAPL) added another 0.5% after the tech giant received a stock upgrade from UBS Group AG�(NYSE: UBS). The Swiss bank hiked its price target on AAPL stock from $190 to $210 and cited the tech firm's growing services business as a driver of increased revenue. Shares of Twitter Inc. (NYSE:
• [By Max Byerly]

  BigONE Token (CURRENCY:BIG) traded 5.2% lower against the dollar during the one day period ending at 9:00 AM ET on June 24th. During the last week, BigONE Token has traded down 22% against the dollar. One BigONE Token token can currently be bought for approximately $1.76 or 0.00029748 BTC on major exchanges including OTCBTC and BigONE. BigONE Token has a total market capitalization of $0.00 and approximately $188.00 worth of BigONE Token was traded on exchanges in the last day.

• [By Shane Hupp]

  Big Lots (NYSE: BIG) is one of 12 publicly-traded companies in the “Variety stores” industry, but how does it weigh in compared to its peers? We will compare Big Lots to similar companies based on the strength of its profitability, earnings, dividends, institutional ownership, analyst recommendations, risk and valuation.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Big Lots (BIG)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Big Lots, Inc. (NYSE: BIG) shares fell 9.6 percent to $37.01 in pre-market trading after the company reported weaker-than-expected results for its first quarter and issued downbeat earnings forecast. Tilly's, Inc. (NYSE: TLYS) fell 5.7 percent to $12.98 in pre-market trading after rising 12.69 percent on Thursday. Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) fell 4.2 percent to $6.39 in pre-market trading after dropping 4.71 percent on Thursday. Sunlands Online Education Group (NYSE: STG) fell 4.2 percent to $9.13 in pre-market trading. Safe Bulkers, Inc. (NYSE: SB) fell 4.2 percent to $3.42 in pre-market trading after climbing 12.62 percent on Thursday. Ulta Beauty, Inc. (NASDAQ: ULTA) fell 4.1 percent to $236.80 in pre-market trading. Ulta Beauty reported upbeat results for its first quarter, but issued weak second-quarter earnings and sales guidance. GameStop Corp. (NYSE: GME) shares fell 3.8 percent to $12.70 in pre-market trading. GameStop reported in-line earnings for its first quarter, while sales missed estimates. Workday, Inc. (NASDAQ: WDAY) fell 3.2 percent to $126.85 in the pre-market trading session after the company posted Q1 results. Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 3 percent to $57.15 in pre-market trading
• [By Lisa Levin]

  Breaking news

  Big Lots, Inc. (NYSE: BIG) reported weaker-than-expected results for its first quarter and issued downbeat earnings forecast. Lululemon Athletica inc. (NASDAQ: LULU) reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance. Ulta Beauty Inc (NASDAQ: ULTA) reported upbeat results for its first quarter, but issued weak second-quarter earnings and sales guidance. Costco Wholesale Corporation (NASDAQ: COST) reported better-than-expected results for its third quarter.

Hot Performing Stocks To Buy Right Now: Urban Outfitters Inc.(URBN)

Advisors' Opinion:

• [By Chris Lange]

  Urban Outfitters Inc. (NASDAQ: URBN) released its most recent quarterly results after the markets closed on Tuesday. The firm ultimately came out on top of this most recent report, keeping its strong winning streak alive, and thanks to the help of analysts rushing to its side.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Urban Outfitters (URBN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Chris Lange]

  Urban Outfitters Inc. (NASDAQ: URBN) also will report its most recent quarterly results on Tuesday. The consensus estimates call for $0.63 in EPS and $1.08 billion in revenue. Shares were last seen trading at $36.48, in a 52-week range of $16.19 to $38.06. The consensus price target is $34.62.

• [By Garrett Baldwin]

  Markets have been under pressure once again by the U.S. Federal Reserve. Inflation levels are going through the roof… but the people in charge of managing it have been lying to Americans for years. Now it's time to get even.�Money Morning�Liquidity Specialist Lee Adler has the perfect way to make a lot of money when no one is looking.�Read it here.

  The Top Stock Market Stories for Tuesday Despite all of the political noise, both China and the United States have agreed to take a step back and seriously pursue talks that may prevent further tariff impositions. The biggest development on the trade front is that the Trump administration is considering a plan to lift a sales ban on Chinese mobile giant ZTE. Shares of Micron Technology Inc. (Nasdaq: MU) are pushing higher after the company announced a $10 billion plan to buy back stock. Micron reported earnings on Monday, and the Boise-based firm easily topped Wall Street expectations. Facebook Inc. (Nasdaq: FB) was pushing a bit higher on Tuesday as the firm prepared to address data privacy issues in Europe. The social media giant's CEO, Mark Zuckerberg, is set to speak before European lawmakers this morning. Zuckerberg will testify this morning, just three days after the European Union enforced more stringent laws on consumer data protection. Three Stocks to Watch Today: GM, KSS, TSLA Shares of General Motors Co. (NYSE: GM) were pushing higher after the auto giant reported that China will be lifting restrictions on U.S. automotive parts and cars. But GM isn't the only beneficiary. Look for shares of Ford Motor Co.�(NYSE: F) and Fiat Chrysler Automobiles NV�(Nasdaq: FCAU) to also get a boost out of the Chinese economy. Shares of Kohl's Corp.�(NYSE: KSS) popped 5% after the firm beat earnings expectations and easily topped same-store sales during the first quarter. The company also raised its 2019 earnings numbers, which helped fuel investor sentiment. Shares of Tesla Inc. (Nasdaq: TSLA) are in focus
• [By Stephan Byrd]

  TJX Companies (NYSE: TJX) and Urban Outfitters (NASDAQ:URBN) are both retail/wholesale companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Hot Performing Stocks To Buy Right Now: HSBC Holdings plc(HSBC)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Fluor Corporation (NYSE: FLR) fell 13.4 percent to $51.10 in pre-market trading after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year. Integrated Media Technology Limited (NASDAQ: IMTE) fell 9.8 percent to $28.97 in pre-market trading after surging 46.29 percent on Thursday. Gogo Inc. (NASDAQ: GOGO) shares fell 8.2 percent to $8.81 in pre-market trading after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow. Sharing Economy International Inc. (NASDAQ: SEII) shares fell 7.5 percent to $3.98 in pre-market trading after climbing 22.16 percent on Thursday. Arista Networks, Inc. (NYSE: ANET) fell 7.4 percent to $248.00 in pre-market trading following first-quarter earnings. Web.com Group, Inc. (NASDAQ: WEB) fell 6.7 percent to $18.00 in pre-market trading after reporting Q1 results. Varex Imaging Corporation (NASDAQ: VREX) fell 5.2 percent to $34 in pre-market trading after reporting Q2 results. Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) shares fell 5.2 percent to $7.60 in pre-market trading after dropping 3.02 percent on Thursday. AMN Healthcare Services, Inc (NYSE: AMN) shares fell 4.7 percent to $61.70 in pre-market trading following Q1 earnings. HSBC Holdings plc (NYSE: HSEA) fell 4.6 percent to $25.15 in pre-market trading after reporting Q1 results. Stratasys Ltd. (NASDAQ: SSYS) shares fell 4 percent to $16.66 in pre-market trading after dropping 2.86 percent on Thursday. Melco Resorts & Entertainment Limited (NASDAQ: MLCO) fell 4 percent to $30.65 in pre-market trading. Century Aluminum Co (NASDAQ: CENX) fell 4 percent to $15.76 in pre-market trading following Q1 results. HSBC Holdings plc (NYSE: HSBC) shares fell 3.5 percent to $48.10 in pre-market tr
• [By Matthew Cochrane]

  In Kenya, 28 million consumers can now seamlessly integrate their M-Pesa accounts with PayPal. In Spain, CaixaBank and Bankia both further integrated their online sites with PayPal. HSBC Holdings PLC (NYSE:HSBC) now allows corporate customers in the U.K. to pay distributions to beneficiaries through PayPal, a capability to be rolled out across Europe in the coming months. Barclays PLC (NYSE:BCS) announced a strategic partnership that enables its customers to more easily link their accounts to PayPal, and soon to use their reward points on PayPal's digital platform.

• [By Money Morning Staff Reports]

  Here's what you need to know.

  The Top Cryptocurrency Stories for May 14, 2018 China will soon release an official report on about 30 decentralized currencies. "This independent analysis of cryptocurrencies and global public blockchain technology demonstrates the confidence of the Chinese government in the technology, and will act as a guide," regulators said. Markets are also keeping an eye on Facebook Inc. (Nasdaq: FB). Last week, Cheddar reported that the social media giant is considering the creation of its own cryptocurrency. The development is surprising, given that the company had banned advertising related to cryptocurrencies earlier this year. The Facebook cryptocurrency would be used to facilitate payments on its platform. It's worth noting that the head of the group that is exploring the Facebook coin is a board member of the cryptocurrency exchange Coinbase. Will cryptocurrencies be part of a future bailout or economic stimulus effort by the U.S. Federal Reserve? That was suggested in new report by research analysts at Morgan Stanley (NYSE: MS). The Wall Street investment bank suggests that state-sponsored cryptocurrencies could allow central banks to press interest rates into negative territory. "Freely circulating paper notes and coins (cash) limits the ability of the central banks to force negative deposit rates," the report reads. "A digital version of cash could theoretically allow negative deposit rates to be charged on all money in circulation within any economy." Finally, markets are reacting positively to the announcement that ING Bank and HSBC Holdings Plc. (NYSE: HSBC) engaged in their first trade ever using blockchain technology. The two engaged in a trade on behalf of Cargill to finance a shipment of soybeans from Argentina to Malaysia. The Shocking Reason Why We Think Bitcoin Could Hit $100,000 (and How You Could Make Millions)

  Money Morning Defense and Tech Specialist – and cryptocurrency legend – Michael Robinson ju

• [By Stephan Byrd]

  HSBC (NYSE:HSBC) was upgraded by stock analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued to investors on Tuesday, The Fly reports.

This High-Yield Stock Continues to Fuel up Its Dividend Growth Engine

Enterprise Products Partners (NYSE:EPD) has delivered spectacular dividend growth since its formation nearly two decades ago. Overall, the midstream master limited partnership (MLP) has increased its payout 65 times since going public in 1998, including in each of the last 56 quarters. That distribution growth streak is showing no signs of ending because the company continues to develop new expansion projects that should give it the fuel to keep growing its 6.1%-yielding distribution.

Quickly coming up with a solution

Enterprise recently announced that it plans to build a crude oil export terminal off the coast of Texas. The terminal would have the capability to fully load Very Large Crude Carriers (VLCCs), which are mammoth oil tankers capable of transporting 2 million barrels of oil. Because of their size, they're the most cost-effective way to ship oil to Asia and Europe.

Image source: Getty Images.

Enterprise recently started loading crude on VLCCs at its Texas City terminal. However, because of port restrictions, Enterprise can only load 1.1 million barrels into VLCCs at this terminal. From there, the vessel must enter a lightering zone, which is an area away from the port where smaller tankers known as lightering vessels fill up the VLCC to its capacity. This process is more time-consuming and costlier than if Enterprise could fully load a VLCC.

That's why the company wants to develop an offshore crude oil terminal to solve this problem. The initial designs include building 80 miles of pipeline to a new offshore terminal capable of loading 85,000 barrels an hour into VLCCs. This facility would expand the company's capabilities and keep it at the forefront as one of the few with the capacity to export crude oil from the U.S., which will come in handy as output continues rising in the coming years.

Steadily refilling the tank

This project is the latest development by Enterprise Products Partners, which has been actively expanding its footprint. The company recently finished a major expansion wave after bringing $4.5 billion of growth projects online in 2017. Those investments, when combined with improving oil prices, position the company to deliver significant cash flow growth this year, giving it clear line-of-sight to increase the distribution each quarter.

However, even after finishing that large slate of projects, Enterprise entered 2018 with another $5.2 billion of expansions under construction that it expects to complete through 2019. While the company already finished another $800 million of those projects through the early part of the second quarter, it has quickly refilled the tank thanks to the success of its commercial and project development teams and currently has $4.9 billion of projects under way. That number appears poised to continue rising thanks to the development of the offshore oil export terminal as well as other projects the company has in the pipeline.

These expansions position Enterprise to grow cash flow at a steady pace for the next few years, giving it more fuel to increase its distribution to investors. In fact, after slowing its distribution growth rate last year so that it could retain more cash to help fund its burgeoning expansion backlog, the company could reaccelerate in 2019 given the volume of projects it's bringing online.

The outlook for income investors continues to brighten

Enterprise Products Partners has found no shortage of expansion opportunities in recent years due to its focus on providing solutions to the energy industry's infrastructure issues. That ability to solve problems has provided the company with several high-return expansion opportunities that have enabled it to consistently grow cash flow -- and its distribution. With more new projects on the way, it appears as though Enterprise should have no problem keeping that streak going for the next several years.�

��I Don��t Know About You, but I��m Worried��

��What trade war?�� asked an Op-Ed writer in Tuesday��s Washington Post, triumphantly.

��Investors on Monday continued shrugging off fears that President Trump’s escalation of trade hostilities will put a dent in share prices.��

We almost pity the poor fellow �� all that egg he had scrape from his face.

The Dow Jones tumbled 219 trade-warring points yesterday �� and once again turned negative on the year.

Damage spread far�� and wide… like a virus unleashed in a busy airport:

S&P �� down.

Nasdaq �� down.

Global stock markets �� down.

Oil, gold, commodities in general �� down.

Copper, which many consider a true barometer of global growth, plunged as much as 4% yesterday.

The one major exception?

The dollar �� the dollar was up �� which partly explains the commodities shellacking.

But the central reason for yesterday��s far-flung panic is trade��

The president threatened additional tariffs on another $200 billion of imported Chinese goods.

This, coming days after the U.S. and China imposed $34 billion of tariffs on the other��s goods.

This, coming as Trump harrumphs he may seek tariffs on over $450 billion of Chinese wares.

Markets made good many of yesterday��s losses today.

They nonetheless remain, to cadge a hackneyed phrase, ��on edge.��

��We view the White House��s announcement of an additional $200 billion round of tariffs as significant in escalating the tensions closer to a full-blown tit-for-tat trade war,�� warns Bart Melek of TD Securities.

Commerzbank analysts affirm:

��There is growing concern among market participants that the trade war will affect the real economy and put the brakes on global economic growth.��

The way ahead is a gauntlet… and arrows come zinging from every direction��

To trade wars we must add rate hikes. Quantitative tightening. Inverting yield curves. Overvalued stocks. Sky-shooting deficits. More.

��I don��t know about you, but I��m worried,�� confesses Kevin Muir, market strategist at East West Investment Management, listing a parade of horribles:

The economic cycle is long in the tooth. Equity valuations are stretched. The yield curve is flattening. Emerging markets and other liquidity-sensitive markets are sagging. The Federal Reserve is raising rates while also attempting the never-before-accomplished feat of reversing a decade of quantitative easing �� seemingly oblivious to the hornet��s nest they are walking into. And President Trump seems determined to antagonize as many trading partners as possible before the summer holidays begin in earnest.

Sell everything is the message �� include the sink in the kitchen, the floorboards, the wife, the children.

But is that the message?

��Although every bone in my body wants to sell this market,�� Muir anguishes, ��I am petrified this trade is so obvious, it can��t be right.��

It can’t be right?

What about the economic cycle you mentioned�� equity valuations�� the yield curve�� emerging markets�� the Federal Reserve�� Donald Trump��s antagonizings?

I know all the reasons why the stock market should go down. The investor in me agrees 100% with the skeptics who worry we are late-cycle and that risks are rising. But the trader in me is even more concerned that everyone is already positioned for this outcome�� I don��t think the Market Gods will allow this many to catch the top. Markets don��t roll over with the vast majority of market participants calling for a correction. No, they top with buyers being absolutely convinced the only way is up.

The consensus-busting conclusion?

��That path is higher �� not lower.��

A contrarian we have here.

Many boastful types bellow contrarian gloats and gurgles �� ��I never follow the crowd. I always do the opposite. I��m my own man.��

In reality�� few can summon the courage to stray from the herd��s comforting embrace.

The pull proves irresistible for most.

Do you have the nerve?

Regards,

Brian Maher
Managing editor, The Daily Reckoning

Hot Heal Care Stocks For 2019

tags:a,HIIQ,MYOK,USA,ELGX,REG,

The Nifty, which started on a strong note on Friday, failed to hold on to its momentum and quickly pared gains to closed just above its crucial support level of 10,600. For the week, the index ended 0.7 percent lower.

The index was largely dominated by the bears and closed near its intraday low, making a ��Bearish Belt Hold�� kind of pattern on the daily charts. On the weekly charts, the Nifty formed a bearish candle after closing in the green for the past five weeks.

The�Nifty, after�breaking�below 10,650, got some support at its 13-day exponential moving average (DEMA) to close at 10,618, down 61.40 points.�The index�opened at 10,700.45, which was also the intraday high. The bears pushed it to an intraday low of 10,601.60, which was within touching distance of its crucial support placed around 10,600.

Investors are advised to stay cautious as the weekly chart pattern suggests a pause in momentum, at least for the time being. A firm close below 10,600 could fuel selling pressure in the Nifty, while a close above 10,700 could put the bulls back in charge, experts suggested.

Hot Heal Care Stocks For 2019: Jersey Elec.(a)

Advisors' Opinion:

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Agilent Technologies, Inc. (NYSE: A) which traded down about 10% at $62.51. The stock��s 52-week range is $55.60 to $75.00. Volume was 14 million compared to the daily average volume of 2.6 million.

• [By ]

  These include: Adobe Systems Inc. (ADBE) , ADT Inc. (ADT) , Agilent Technologies Inc. (A) , Allergan Plc (AGN) , Anthem Inc. (ANTM) , Apple Inc. (AAPL) , Boston Scientific (BSX) , Cigna Corp. (CI) , Discovery Communications (DISCA) and Dr. Pepper Snapple Group Inc. (DPS) .

• [By Garrett Baldwin]

  Eight Seconds… $1,260 Richer: Words can't describe what you'll see in this shocking footage – because you'll witness, live on camera, one man become $4,238 richer with just three clicks of a mouse. And if you follow the simple instructions in this video, you'll learn how to set yourself up for an instant $2,918 payday opportunity. You need to see this to believe it…

  Three Stocks to Watch Today: COP, HD, HSBC ConocoPhillips (NYSE: COP) has seized assets from the Venezuelan-owned firm PDVSA in the Caribbean. The company won a court case that will allow it to take over assets owned by the Venezuelan government. The court enabled the seizures as part of a broader plan to allow the firm to recoup roughly $2 billion following the 2007 nationalization of its assets in Venezuela by the huge Castro-led government. Monday will be a quiet day on the earnings front. Investors are looking to Tuesday's calendar, when The Home Depot Inc. (NYSE: HD) reports earnings. Tomorrow, Wall Street analysts expect that Home Depot will report earnings per share of $2.07 on top of $25.2 billion in revenue. Investors will be hoping that the company reports strong profits thanks to an improving U.S. economy and the recent tax reform law. Expect a lot of chatter today about blockchain technology. That's because ING Bank and HSBC Holdings Plc.�(NYSE: HSBC) announced over the weekend that they engaged in their first trade ever using blockchain technology. The two engaged in a trade on behalf of Cargill to finance a shipment of soybeans from Argentina to Malaysia. Today, look for earnings reports from Agilent Technologies (NYSE: A), Itron Inc.�(Nasdaq: ITRI), Vipshop Holdings Ltd.�(Nasdaq: VIPS), Amyris Biotechnologies Inc. (Nasdaq: AMRS), Sky Solar Holdings Ltd.�(Nasdaq: SKYS), Mazor Robotics Ltd.�(Nasdaq: MZOR), China Lodging Group Ltd. (Nasdaq: HTHT), and Mimecast Ltd.�(Nasdaq: MIME).

  Follow�Money Morning��on��Facebook,�Twitter, and�LinkedIn.

• [By Max Byerly]

  M&T Bank Corp grew its stake in Agilent Technologies (NYSE:A) by 5.3% during the first quarter, HoldingsChannel.com reports. The fund owned 30,717 shares of the medical research company’s stock after acquiring an additional 1,539 shares during the period. M&T Bank Corp’s holdings in Agilent Technologies were worth $2,056,000 at the end of the most recent quarter.

• [By Lisa Levin]

  Some of the stocks that may grab investor focus today are:

  Wall Street expects Agilent Technologies, Inc. (NYSE: A) to post quarterly earnings at $0.64 per share on revenue of $1.21 billion after the closing bell. Agilent shares rose 0.86 percent to close at $69.45 on Friday. Analysts expect Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) to report quarterly earnings at $0.14 per share on revenue of $438.40 million before the opening bell. Hanwha Q CELLS shares fell 0.29 percent to close at $6.92 on Friday. NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders. NiSource shares rose 0.08 percent to close at $24.93 on Friday. Analysts are expecting Vipshop Holdings Limited (NYSE: VIPS) to have earned $0.18 per share on revenue of $3.10 billion in the latest quarter. Vipshop will release earnings after the markets close. Vipshop shares rose 0.20 percent to $15.14 in after-hours trading.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Dan Caplinger]

  Tuesday was a down day for stocks, with the Dow Jones Industrial Average falling early to triple-digit losses and other major benchmarks declining by a similar percentage. The yield on the 10-year Treasury jumped well above the 3% mark, leading to speculation that a sustained upward move for interest rates could start to sap away some of the strength of the nearly decadelong bull market in stocks. Adding to the downward pressure was badly received news from several prominent individual companies. Switch (NYSE:SWCH), Vipshop Holdings (NYSE:VIPS), and Agilent Technologies (NYSE:A) were among the worst performers on the day. Here's why they did so poorly.

Hot Heal Care Stocks For 2019: Health Insurance Innovations, Inc.(HIIQ)

Advisors' Opinion:

• [By Logan Wallace]

  Health Insurance Innovations (NASDAQ:HIIQ) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Health Insurance Innovations (HIIQ)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Health Insurance Innovations (NASDAQ:HIIQ) insider Michael W. Kosloske sold 1,300,000 shares of the firm’s stock in a transaction on Thursday, June 7th. The shares were sold at an average price of $31.00, for a total value of $40,300,000.00. Following the completion of the sale, the insider now directly owns 100 shares in the company, valued at approximately $3,100. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

• [By Shane Hupp]

  Health Insurance Innovations (NASDAQ:HIIQ) saw unusually-high trading volume on Thursday after the company announced better than expected quarterly earnings. Approximately 2,255,517 shares were traded during mid-day trading, an increase of 457% from the previous session’s volume of 404,884 shares.The stock last traded at $28.70 and had previously closed at $27.65.

Hot Heal Care Stocks For 2019: MyoKardia, Inc.(MYOK)

Advisors' Opinion:

• [By Logan Wallace]

  Shares of Myokardia Inc (NASDAQ:MYOK) have been assigned an average recommendation of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $69.50.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on MyoKardia (MYOK)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Heal Care Stocks For 2019: Liberty All-Star Equity Fund(USA)

Advisors' Opinion:

• [By ]

  Given that the Fed has indicated it would welcome a modest overshoot in inflation, markets would likely need to see wages grow by 0.4 percent or 0.5 percent to gain confidence in a fourth 2018 hike, according to Priya Misra, head of global rates strategy at TD Securities (USA) LLC.

• [By ]

  These are the participating banks:

  In the U.S.: Ally Financial, American Express, Bank of America, Bank of New York Mellon, BB&T, Capital One, CIT, Citigroup, Citizens Financial, Comerica, Discover Financial, Fifth Third, Goldman Sachs, Huntington, JPMorgan Chase, KeyBanc, M&T, Morgan Stanley, Northern Trust, PNC Financial, Regions Financial, State Street, SunTrust, U.S. Bancorp, Wells Fargo, and Zions. Non-U.S. firms: Barclays US, BBVA Compass Bancshares, BMO Financial, BNP Paribas USA, Credit Suisse Holdings (USA), Deutsche Bank USA, HSBC North America Holdings, MUFG Americas Holdings, RBC USA, Santander Holdings USA, TD Group US, UBS Americas

  Here’s a sample of recent analyst commentary:

Hot Heal Care Stocks For 2019: Endologix, Inc.(ELGX)

Advisors' Opinion:

• [By Stephan Byrd]

  Endologix (NASDAQ:ELGX) was upgraded by investment analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Wednesday.

Hot Heal Care Stocks For 2019: Regency Centers Corporation(REG)

Advisors' Opinion:

• [By Logan Wallace]

  Fort Washington Investment Advisors Inc. OH purchased a new position in Regency Centers Co. (NYSE:REG) during the first quarter, HoldingsChannel.com reports. The firm purchased 8,200 shares of the real estate investment trust’s stock, valued at approximately $484,000.

• [By Logan Wallace]

  State of Tennessee Treasury Department raised its holdings in shares of Regency Centers Corp (NYSE:REG) by 402.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 192,496 shares of the real estate investment trust’s stock after purchasing an additional 154,218 shares during the quarter. State of Tennessee Treasury Department’s holdings in Regency Centers were worth $11,353,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Regency Centers (REG)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Regency Centers (REG)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  ValuEngine upgraded shares of Regency Centers (NYSE:REG) from a sell rating to a hold rating in a research note published on Friday.

  Several other equities research analysts also recently issued reports on REG. Jefferies Financial Group set a $64.00 price objective on shares of Regency Centers and gave the stock a hold rating in a research note on Tuesday, February 27th. Wells Fargo & Co reiterated an outperform rating and set a $65.00 price objective (down from $76.00) on shares of Regency Centers in a research note on Friday, March 2nd. SunTrust Banks set a $67.00 price objective on shares of Regency Centers and gave the stock a buy rating in a research note on Friday, March 2nd. Deutsche Bank decreased their price objective on shares of Regency Centers from $73.00 to $72.00 and set a hold rating for the company in a research note on Monday, March 19th. Finally, Robert W. Baird reiterated a buy rating and set a $68.00 price objective on shares of Regency Centers in a research note on Wednesday, March 21st. Eight analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. Regency Centers presently has a consensus rating of Buy and a consensus price target of $68.32.

LifePoint Health (LPNT) Receiving Positive Media Coverage, Analysis Shows

Headlines about LifePoint Health (NASDAQ:LPNT) have trended positive this week, Accern reports. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LifePoint Health earned a news impact score of 0.44 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.0016583450414 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

LifePoint Health traded up $0.30, hitting $48.75, during trading on Tuesday, MarketBeat reports. 504 shares of the company’s stock traded hands, compared to its average volume of 690,271. The firm has a market cap of $1.87 billion, a price-to-earnings ratio of 13.46, a PEG ratio of 1.24 and a beta of 0.52. The company has a quick ratio of 1.55, a current ratio of 1.76 and a debt-to-equity ratio of 1.28. LifePoint Health has a 1 year low of $41.45 and a 1 year high of $66.05.

Get LifePoint Health alerts:

LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Friday, May 4th. The company reported $1.22 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.13 by $0.09. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.62 billion. LifePoint Health had a net margin of 0.48% and a return on equity of 6.56%. LifePoint Health’s revenue was down 1.7% compared to the same quarter last year. During the same period last year, the firm earned $1.07 earnings per share. analysts anticipate that LifePoint Health will post 4.3 EPS for the current fiscal year.

A number of equities analysts have recently commented on LPNT shares. Robert W. Baird reaffirmed a “buy” rating and set a $54.00 target price on shares of LifePoint Health in a research report on Tuesday, March 27th. Zacks Investment Research raised shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $55.00 target price on the stock in a research report on Wednesday, July 4th. BidaskClub lowered shares of LifePoint Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 26th. Mizuho reissued a “hold” rating and set a $51.00 price objective on shares of LifePoint Health in a report on Thursday, March 22nd. Finally, SunTrust Banks reissued a “hold” rating and set a $58.00 price objective on shares of LifePoint Health in a report on Monday, May 7th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $53.67.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.

Head-To-Head Survey: Spok (SPOK) versus Mobil’nye Telesistemy PAO (MBT)

Spok (NASDAQ: SPOK) and Mobil’nye Telesistemy PAO (NYSE:MBT) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.

Volatility & Risk

Get Spok alerts:

Spok has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, Mobil’nye Telesistemy PAO has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

Profitability

This table compares Spok and Mobil’nye Telesistemy PAO’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Spok	-9.05%	2.84%	2.37%
Mobil’nye Telesistemy PAO	13.76%	45.69%	9.88%

Dividends

Spok pays an annual dividend of $0.50 per share and has a dividend yield of 3.2%. Mobil’nye Telesistemy PAO pays an annual dividend of $0.70 per share and has a dividend yield of 7.5%. Mobil’nye Telesistemy PAO pays out 71.4% of its earnings in the form of a dividend.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Spok and Mobil’nye Telesistemy PAO, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spok	0	0	0	0	N/A
Mobil’nye Telesistemy PAO	0	1	6	0	2.86

Mobil’nye Telesistemy PAO has a consensus target price of $10.75, suggesting a potential upside of 15.59%. Given Mobil’nye Telesistemy PAO’s higher possible upside, analysts clearly believe Mobil’nye Telesistemy PAO is more favorable than Spok.

Valuation & Earnings

This table compares Spok and Mobil’nye Telesistemy PAO’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spok	$171.18 million	1.79	-$15.30 million	N/A	N/A
Mobil’nye Telesistemy PAO	$6.70 billion	1.38	$958.31 million	$0.98	9.49

Mobil’nye Telesistemy PAO has higher revenue and earnings than Spok.

Institutional & Insider Ownership

83.0% of Spok shares are held by institutional investors. Comparatively, 32.3% of Mobil’nye Telesistemy PAO shares are held by institutional investors. 1.6% of Spok shares are held by company insiders. Comparatively, 1.0% of Mobil’nye Telesistemy PAO shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Mobil’nye Telesistemy PAO beats Spok on 9 of the 14 factors compared between the two stocks.

Spok Company Profile

Spok Holdings, Inc., through its subsidiary, Spok, Inc., provides various communications solutions to healthcare, government, and other enterprises in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company provides one-way messaging, including numeric messaging services, which enable subscribers to receive messages comprising numbers, such as phone numbers; and alphanumeric messages, including numbers and letters that enable subscribers to receive text messages. It also offers two-way messaging services that enable subscribers to send and receive messages to and from other wireless messaging devices, such as pagers, personal digital assistants, and personal computers; and voice mail, personalized greeting, message storage and retrieval, and equipment loss and/or maintenance protection to one-way and two-way messaging subscribers. In addition, the company develops, sells, and supports enterprise-wide systems to automate, centralize, and standardize mission critical communications for contact centers, clinical alerting and notification, mobile communications, and messaging, as well as for public safety notifications. Further, it sells devices to resellers who lease or resell them to their subscribers; ancillary services, such as voicemail and equipment loss or maintenance protection, as well as provides a suite of professional services. The company serves businesses, professionals, management personnel, medical personnel, field sales personnel and service forces, members of the construction industry and construction trades, real estate brokers and developers, sales and services organizations, specialty trade organizations, manufacturing organizations, and government agencies. The company was formerly known as USA Mobility, Inc. and changed its name to Spok Holdings, Inc. in July 2014. Spok Holdings, Inc. is headquartered in Springfield, Virginia.

Mobil’nye Telesistemy PAO Company Profile

Public Joint-Stock Company Mobile TeleSystems provides telecommunication services in Russia, Ukraine, Turkmenistan, and Armenia. The company operates through three segments: Russia Convergent, Moscow Fixed Line, and Ukraine. It offers voice and data transmission, Internet access, pay TV, and various value added services through wireless and fixed lines, as well as sells equipment, accessories, and handsets. The company also provides system integration services and IT solutions. Public Joint-Stock Company Mobile TeleSystems has a partnership agreement with Nokia for joint development and deployment of Nokia's new technological solutions, as well as to promote new digital products and services of Mobile TeleSystems Group. The company was founded in 1993 and is based in Moscow, Russia. Public Joint-Stock Company Mobile TeleSystems is a subsidiary of Sistema Finance S.A.

Businesses have 22 Brexit questions no one can answer

Businesses need answers on Brexit �� and fast.

The British Chambers of Commerce released a list of 24 questions on Tuesday that companies are asking about Brexit. With just nine months to go before the divorce, it said the UK government has answered only two.

"We are little closer to the answers businesses need than we were the day after the referendum," Adam Marshall, director general of the BCC, said in a statement. "Business patience is reaching breaking point."

The business lobby group said that companies don't know whether they'll face new regulations, tariffs or customs checks. It's also unclear if they'll be able to move staff between the European Union and the United Kingdom, or be forced to pay new taxes.

The questions range from the fundamental to the practical: "Will my business have to pay mobile roaming charges in the European Union after Brexit," reads one query.

These "are the practical, real-world concerns of businesses of every size and sector, in every part of the United Kingdom," said Marshall.

More than two years have passed since Brits voted to leave the European Union in June 2016, but Prime Minister Theresa May's government has not been able to settle key issues within its own ranks, let alone with its EU partners.

The two biggest sticking points are how to avoid customs checks for goods moving between Britain and the European Union, and how to handle the border between Northern Ireland (part of Britain) and Ireland (part of the European Union).

May will try to make progress on these issues �� and iron out deep divisions within her party �� at a meeting of top government officials on Friday.

The European Union is also pushing May to speed up the process. At a summit held last week, EU leaders called for "realistic and workable" proposals from the United Kingdom.

Brexit confusion is taking its toll as the clock ticks down to March 2019.

Nearly half of EU business executives have already reduced investment in the United Kingdom following the Brexit referendum in June 2016, according to a survey published last week by law firm Baker McKenzie.

Airbus (EADSF) has warned that it could be forced to quit the country if there's no deal on EU trading arrangements. Earlier in June, the head of Britain's top business lobby group said the country's car industry could be wiped out.

Here are more of the key questions businesses need answering now:

Will my company still have access to markets on the same terms as now once we left the European Union? Will my business be able to move skilled staff members between the United Kingdom and European Union in future? Will I be able to continue trading without tariffs with the European Union in the future? Will my goods be subject to new customs rules, procedures and inspections at the UK or EU border in future? Could my shipments be held up and delayed?

BOE's Past and Future Collide This Week as Hawks Speak Out

LISTEN TO ARTICLE 2:07 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

Investors will get a vision of the Bank of England’s past, present and future this week.

#lazy-img-319688028:before{padding-top:71.25984251968505%;}

Ian McCafferty 

Bloomberg

Ian McCafferty, who has a reputation for being the Monetary Policy Committee’s most hawkish member, will on Tuesday give what is likely to be his final speech before he leaves the bank in August. At the same time, Jonathan Haskel, the man chosen to replace him, will make his first public appearance in his new capacity before lawmakers in Westminster, where he may give the first signs of his views on policy.

Last Hurrah

BOE's Ian McCafferty has one more meeting left to secure a second rate hike

Source: Bloomberg

.chart-js { display: none; }

Two days later, chief economist Andy Haldane, who shocked markets last week by unexpectedly joining McCafferty and Michael Saunders in voting for an immediate interest-rate increase, is due to make a speech that may see him lay out the reasons for his switch.

The appearances come as markets judge the likelihood of an August hike from the BOE. While all officials agree that a gradual tightening of policy is required, most said this month there was still some value to seeing how the data evolve.

They’ll get two more clues on Friday. The statistics office publishes the final estimate of first-quarter gross domestic product, while the BOE releases data on May mortgage approvals and consumer credit.

Read More: Imperial Professor Haskel Appointed to BOE Rates Committee

Traders currently assign a 67 percent possibility to a rate increase in August, up from less than 50 percent before Haldane’s surprise hawkish tilt. A hike would be a fitting denouement for McCafferty, who has voted for one 18 times across his 63 meetings, with his only success thus far coming last November.

#lazy-img-319687628:before{padding-top:71.25984251968505%;}

Andrew Haldane

Bloomberg

Still, with the stance of McCafferty, and now, Haldane, made public, it may be that Haskel’s confirmation hearing in Parliament may be watched the most closely by investors, even though he doesn’t have a vote in August. It’s possible that the renowned productivity expert and Imperial College Business School professor will be more dovish than his predecessor.

Haskel’s testimony will “tell us a bit more about whether we get a hawk replacing McCafferty from the end of August onwards -- are we about to go from three to two?,” said Victoria Clarke, an economist at Investec in London. “My hunch would be that, much like many others who are fresh to the MPC, he’d be unlikely to jump in and vote for hike immediately if that wasn’t the mood of the committee broadly.”

Syndax Pharmaceuticals: Elucidating The Results Of The Phase 2 ENCORE 601 Trial

An investment operation is one which, upon thorough analysis, promises safety of principal and an adequate return. - Warren Buffett

Syndax Pharmaceuticals (NASDAQ:SNDX) is one of the new companies that we featured within the previous month. Interestingly, the firm recently reported the data for the ENCORE 601 trial. This is a sneak peek preview prior to the data to be presented at the American Society of Clinical Oncology (��ASCO��) Annual Meeting scheduled on June 1-5, 2018 in Chicago, Illinois.

Despite what was seemingly promising data, the market was not impressed and thus the stock tumbled significantly. The elephant in the room is where the shares are heading (and what investors can expect from Syndax). In this research, we��ll elucidate the recent clinical findings in its appropriate context to gauge where the shares are heading.

Figure 1: Syndax stock chart. (Source: StockCharts).

Fundamental Analysis

First things first, we wish to share an overview for new investors. Accordingly, Syndax Pharmaceuticals is headquartered in Waltham MA. The company is focusing on the therapeutic innovation and commercialization to service the oncology market. Leveraging on its immuno-oncology expertise, the firm is developing two potential best-in-class assets, entinostat and SNDX-6352 (as depicted in figure 2). For an in-depth discussion of the underlying science of entinostat and SND-6352, investors can refer to our initial analytical research on Syndax.

Figure 2: Therapeutic pipeline (Source: Syndax)

As alluded, Syndax reported the preliminary outcomes of the Phase 2 (ENCORE 601) trial on May 17, 2018. As a Phase 1B/2 trial investigating entinostat in combinations with pembrolizumab (Keytruda) of Merck (NYSE:MRK), ENCORE 601 is assessing the aforesaid combo regimen in multiple cohorts of PD-L1 treatment-naive and pre-treated cancers, including non-small cell lung cancer (��NSCLC��), melanoma, and microsatellite stable colorectal cancer (��MSS-CRC��).

At the time of interim analysis (i.e. data cut-off), there were six of 57 patients with NSCLC on the combination regimen who demonstrated partial responses for an 11% objective response rate (��ORR��). The median duration of response (��DOR��) was 4.6 months, with the longest observed response over 14 months. At cut-off, seven patients remain on study. Of note, these patients are extremely sick patients (with 22 or 38% cases already resistant to prior PD-L1 therapy); hence the ORR could not be as robust as what the market had expected. Commenting on the latest data development, the CEO (Dr. Morrison) remarked:

The additional data from the ENCORE 601 program continue to support the potential for the entinostat-pembrolizumab combination to serve as an effective therapeutic option across a variety of indications. We are especially pleased to be able to share preliminary findings from our efforts to identify biomarkers that could aid in predicting which patients may derive a clinical benefit from this combination therapy. We have now identified a potential registration pathway in NSCLC and look forward to providing further updates as our plans come together.

That aside, it��s interesting that the blood samples were collected and analyzed for 51 of the 57 NSCLC patients enrolled. Accordingly, the pre-treated baseline level of various markers was measured. One key assessment that stood out was the immune cells coined ��monocytes,�� which are immature macrophages - the immune cells that engulf pathogens and cancers. As follows, the early data explicated that patients with a higher level of monocytes (14 patients) demonstrated an elevated ORR of 29%, thereby representing 4 partial responders (��PR��) out of 14 patients as mentioned.

In addition, this subgroup remarkably showed the PFS of 5.4 months: this is much higher than the 2.8-month average for NSCLC managed with the 3rd-line chemotherapy (following progression after platinum doublet and PD-L1 treatment). The therapeutic effects of the combo drug are seemingly dependent on the monocytes level. As demonstrated in the patients with lower baseline levels of monocytes, the ORR was only 5% (2 PRs out of 37 patients) and the PFS was simply 2.5 months.

It is imperative to note that the overall patient population (n=57) achieved a PFS of 2.7 months, which is slightly lower than the aforesaid 2.8 mark. Therefore, it is unlikely that the entinostat-Keytruda will demonstrate key advantages over the 3rd-line regimen. Perhaps, the market was reacting negatively to this outcome. Be that as it may, the subpopulation is the key value driver of the NSCLC franchise. With 92% improvement over the standard 3rd-line chemotherapy, it��s most likely that this can be developed for the patients with a higher level of monocytes.

Based upon these findings, Syndax has identified a potential registration path in patients with NSCLC who have progressed on a PD-L1 inhibitor. The trial is expected to start by the end of 2018. Asides from Dr. Morrison, the Director of Thoracic Medicine Oncology Program at NYU Langone Perlmutter Cancer Center (Dr. Leena Gandhi) enthused:

NSCLC patients whose disease has progressed on PD-L1 and chemotherapy are in need of options that offer meaningful clinical benefits. Initial findings from this cohort of NSCLC patients receiving the entinostat-pembrolizumab combination provide encouraging benefit in ORR and PFS. Although more data is needed, promising results for a population of patients with high monocyte counts further highlight that a selection strategy may lead to enhanced benefits for patients.

Investors should be cognizant that while the strong results for the aforementioned combo franchise were not achieved for NSCLC in the overall patient population, it certainly did for the subcohort. Like cobimetinib of Exelixis (NASDAQ:EXEL) that did not procure strong clinical outcomes for the advanced colorectal cancer, nevertheless, it delivers robust results and is approved to treat resistant melanoma. The key point in the ENCORE 601 study is that it measures a vast number of biomarkers' assessment of pre- and on-treatment to better guide registration-directed studies that are most likely to bear fruits.

Final Remarks

Syndax is riding on the power of two lead molecules (entinostat and SNDX-6352) to power an enriched pipeline that can deliver hope to patients afflicted by various deadly cancers. If the reporting for the Phase 3 (E2112) within months turns out positive as we prognosticated, the share can appreciate by approximately one fold. Given the various partnership with Merck and Roche (OTCQX:RHHBY) for the co-development of entinostat with their flagship molecules (Keytruda, Tecentriq, and Bavencio), the company can get acquired if it demonstrates the strong clinical outcomes.

Asides from entinostat, SNDX-6352 is an interesting molecule that can deliver the long-term growth prospects. With many catalysts powering this firm and the asymmetric rewards to risks signified that the company can be a multibagger investment. The main concern for Syndax is if entinostat and the combo can deliver positive Phase 3 data. Since the most value in this company resides in entinostat, a negative reporting can induce the stock to depreciate by over 80%, and vice versa.

Author��s Notes: We��re honored that you took the time to read our market intelligence. Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaborations with Analyst Vu, and other PhDs), Integrated BioSci Investing (��IBI��) is delivering stellar returns. To name a few, Nektar, Spectrum, Atara, and Kite procured over 324%, 144%, 258%, and 83% profits, respectively. Our secret sauce is extreme due diligence with expert data analysis. The service features a once-weekly exclusive Alpha-Intelligence article, daily analysis/consulting, and model portfolios. Of note, there is an IBI version of this article that is a higher-level intelligence with extensive details, in which we published in advanced and exclusively for our subscribers. And, we invite you to subscribe to our marketplace now to lock in the current price and save money for the future.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: Our research articles are best used as starting points in your own due diligence. We are not registered investment advisors and our articles are not construed as professional investment advice. Many new research are requests from private investors of our services (Integrated BioSci Investing and Dr. Tran BioSci), who either paid or donated us to support our efforts (in assisting investors and bioscience innovators to deliver hopes to patients). That aside, I like to inform readers of Seeking Alpha's recent policy change, in which the company implemented the paywall (not only to our articles but to all articles that are published over 10-day). This is in place, as the company is, after all, a business. And, the revenues from ads are not adequate to support the high-quality research that the company is providing. If you are a REAL TIME FOLLOWER, you will be notified immediately of our new research for you to continue to benefit from our due diligence. You can also gain access to all of my old articles and much more by taking the 2-week FREE trial of my marketplace, Integrated BioSci Investing.

IPG Photonics Co. (IPGP) Shares Bought by Tredje AP fonden

Tredje AP fonden boosted its position in shares of IPG Photonics Co. (NASDAQ:IPGP) by 57.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,160 shares of the semiconductor company’s stock after acquiring an additional 1,150 shares during the quarter. Tredje AP fonden’s holdings in IPG Photonics were worth $737,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in IPGP. Nisa Investment Advisors LLC boosted its holdings in IPG Photonics by 700.0% during the 4th quarter. Nisa Investment Advisors LLC now owns 4,000 shares of the semiconductor company’s stock valued at $857,000 after acquiring an additional 3,500 shares during the period. Bank of Montreal Can boosted its holdings in IPG Photonics by 243.5% during the 4th quarter. Bank of Montreal Can now owns 37,529 shares of the semiconductor company’s stock valued at $8,036,000 after acquiring an additional 26,605 shares during the period. Schwab Charles Investment Management Inc. boosted its holdings in IPG Photonics by 1.2% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 142,852 shares of the semiconductor company’s stock valued at $30,589,000 after acquiring an additional 1,653 shares during the period. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in IPG Photonics during the 4th quarter valued at about $128,000. Finally, State of Alaska Department of Revenue purchased a new position in IPG Photonics during the 4th quarter valued at about $556,000. Institutional investors own 57.16% of the company’s stock.

Get IPG Photonics alerts:

IPGP stock opened at $246.16 on Thursday. The company has a current ratio of 9.54, a quick ratio of 7.71 and a debt-to-equity ratio of 0.02. The stock has a market capitalization of $13.16 billion, a price-to-earnings ratio of 33.91, a P/E/G ratio of 2.41 and a beta of 1.85. IPG Photonics Co. has a 1 year low of $136.60 and a 1 year high of $264.11.

IPG Photonics (NASDAQ:IPGP) last posted its quarterly earnings results on Tuesday, May 1st. The semiconductor company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.80 by $0.13. The company had revenue of $359.90 million for the quarter, compared to analyst estimates of $346.35 million. IPG Photonics had a return on equity of 21.59% and a net margin of 25.56%. IPG Photonics’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.38 EPS. equities analysts forecast that IPG Photonics Co. will post 8.48 EPS for the current fiscal year.

A number of equities analysts recently commented on the company. BidaskClub upgraded IPG Photonics from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 12th. Needham & Company LLC raised their target price on IPG Photonics from $230.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Sanford C. Bernstein assumed coverage on IPG Photonics in a report on Wednesday, April 18th. They set an “outperform” rating and a $294.00 target price for the company. Zacks Investment Research cut IPG Photonics from a “buy” rating to a “hold” rating in a report on Tuesday, April 24th. Finally, ValuEngine upgraded IPG Photonics from a “buy” rating to a “strong-buy” rating in a report on Wednesday, May 2nd. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $239.10.

In other IPG Photonics news, major shareholder Valentin Gapontsev Trust I sold 2,000 shares of the stock in a transaction dated Monday, May 21st. The stock was sold at an average price of $245.63, for a total value of $491,260.00. Following the sale, the insider now owns 7,565,999 shares of the company’s stock, valued at approximately $1,858,436,334.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William S. Hurley sold 3,500 shares of the stock in a transaction dated Wednesday, March 14th. The shares were sold at an average price of $255.93, for a total value of $895,755.00. Following the completion of the sale, the director now directly owns 14,505 shares in the company, valued at approximately $3,712,264.65. The disclosure for this sale can be found here. Insiders sold a total of 64,255 shares of company stock worth $15,725,764 in the last ninety days. 33.80% of the stock is owned by corporate insiders.

About IPG Photonics

IPG Photonics Corporation develops and manufactures a range of high-performance fiber lasers, fiber amplifiers, and diode lasers used in various applications primarily in materials processing worldwide. The company's laser products include low, medium, and high power lasers; fiber pigtailed packaged diodes and fiber coupled direct diode laser systems; high-energy pulsed lasers, multi-wavelength and tunable lasers, and single-polarization and single-frequency lasers; laser diode chips and packaged laser diodes; and high power optical fiber delivery cables, fiber couplers, beam switches, chillers, scanners, and other accessories.